Biocept's IPO

Biocept raised a round of funding on February 05, 2014. Investors include Public.

Biocept is a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and biomarker analysis, headquartered in San Diego, California. The company's mission is to improve o…

Articles about Biocept's IPO: